Applications of recombinant Leishmania amazonensis expressing egfp or the β-galactosidase gene for drug screening and histopathological analysis

Experimental Animals

Volumn 52, Issue 2, 2003, Pages 109-118

  Okuno, Takahiro ^a   Goto, Yasuyuki ^a   Matsumoto, Yoshitsugu ^a   Otsuka, Haruki ^a   Matsumoto, Yasunobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

galactosidase; Drug screening; Enhanced green fluorescent protein; Histopathological analysis; Recombinant Leishmania amazonensis

Indexed keywords

5 BROMO 4 CHLORO 3 INDOLYL BETA GALACTOPYRANOSIDE; AMPHOTERICIN B; BETA GALACTOPYRANOSIDE; BETA GALACTOSIDASE; CHLOROPHENOL; DYE; ENHANCED GREEN FLUORESCENT PROTEIN; PLASMID VECTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; DNA SYNTHESIS; DRUG SCREENING; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HISTOPATHOLOGY; IC 50; IN VIVO STUDY; LEISHMANIA; LIGHT ABSORPTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITOSIS; PROMASTIGOTE; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STAINING; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; PARASITOLOGY; PERITONEUM MACROPHAGE;

LEISHMANIA AMAZONENSIS;

ANIMALS; ANTIPROTOZOAL AGENTS; BETA-GALACTOSIDASE; LEISHMANIA; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS;

EID: 0037780215     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.52.109     Document Type: Article

References (25)

1. Aldina, B., Diana, P.S., Gabriel, G.Jr., Hooman, M., Diane, M.P., Amelia, R.J., Roque, A., Robert, B., Manoel, B.N.. Edgar, M.C., and Warren, D.J.Jr. 1991. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop. Med Hyg. 44: 536-546.
2. Abdullah, S.M., Flath, B., and Presber, W. 1998. Mixed infection of human U-973 cells by two different species of Leishmania. Am. J. Trop. Med Hyg. 59: 182-188.
3. Almeid, R.P., Barral N.M., Jesus, A.M.R., Frietas, L.A.R., Carvalho, E.M., and Barral, A. 1996. Biological behavior of Leishmania amazonensis isolated from human with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice. Am. J. Trop. Med. Hyg. 54: 178-184.
4. Balana-Fouce, R., Reguera, R.M., Cubria, J.C., and Ordonez, D. 1998. Review: The pharmacology of Leishmaniasis. Gen. Pharmac. 30: 435-443.
5. Barrel, A., Badaro, R., Diana, P.S., Barral, N.M., Grimaldi, Jr.G., Momen, H., and Calvalho, E.M. 1986. Isolation of Leishmania mexicana amazonensis from the bone marrow in a case of American Visceral Leishmaniasis. Am. J. Trop. Med. Hyg. 35: 732-734.
6. Barral, A. 1991. Leishmania amazonensis is implicated in the whole spectrum of human clinical leishmaniasis. Am. J. Trop. Med. Hyg. 44: 536-546.
7. Berman, J.D. and Lee, L.S. 1984. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages. J Parasit. 70: 220-225.
8. Blackwell, J., Freeman, J., and Bradley, D. 1980. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature. 283: 72-74.
9. Borst, P. and Ouellette, M. 1995. New mechanism of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49: 427-460.
10. Brajtburg, J. and Bolard, J. 1996. Carrier effects on biological activity of Amphotericin B. Clin. Microbiol. Rev. 9: 512-531.
11. Buckner, F.S., Wilson, A.J., and Voorhis, W.C. 1999. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for β-galactosidase. Am. Soc. microbiol. 403-409.
12. Detke, S., Chaudhuri, G., Kink, J.A., and Chang. K.P. 1988. DNA amplification in tunicamycin-resistant Leishmania Mexicana. Multicopies of a single 63-kilobase supercoiled molecule and their expression. J. Biol. Chem. 263: 3418-3424.
13. Chen, D.Q., Kolli, B.K., Yadaba, N., Lu, H.G., Gilman-Sachs, A., Peterson, D.A., and Chang, K.P. 2000. Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro. Infect. Immun. 68: 80-86.
14. Desjardins, R.E., Casero, R.A.Jr., Willet, G.P., Childs, G.E., and Canfield, C.J. 1980. Trypanosoma rhodesiense: Semiautomated microtesting for quantitation of antitrypanosomal activity in vitro. Exp. Parasitol 50: 260-271.
15. Ellis, J.A., Fish, W.R., Sileghem, M., and McOdimba, F. 1993. A colorimetric assay for trypanosome viability and metabolic function. Vet. Parasitol. 50: 143-149.
16. Grimerdi, Jr.G., Tesh, R.B., and McMahon, P.D. 1989. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am. J. Trop. Med. Hyg. 41: 687-725.
17. Hsiao, S.L., Ming, S.J., Chao, K.C., Ping H.C. and Nir, J.K. 1999. Is green fluorescent protein toxic to the living cells? Biochem. Biophysi. Res. Commun. 260: 712-717.
18. Max, G. Tina, N.T., and Eileen, D.F. 1992. Drug resistance in Leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47: 117-126.
19. McFadden, D., Seeber, F., and Boothroid, J.C. 1997. Use of Toxoplasma gondii expressing β-Galactosidase for colorimetric assessment of drug activity in vitro. Antimicrob Agents and Chemother. 1849-1853.
20. Miblitz, A., Motram, J.C., Overath, P., and Abischer. T. 2000. Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol. Biochem. Parasitol. 107: 251-261.
21. Mikus, J. and Steverding, D. 2000. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamer Blue. Parasitol Inter. 48: 265-269.
22. Obexer, W., Schmid, G., and Brun R. 1995. A novel in vitro screening assay for trypanocidal activity using the fluorescent dye BCECF-AM. Trop. Med. Parasitol. 46: 45-48.
23. Sereno, D. and Lemesre, J.L,. 1997. Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro. Parasitol. Res. 83: 401-403.
24. Simon, L.C. 1988. Recent developments in the chemotherapy of leishmaniasis. TIPS-October 9: 376-381.
25. Valdivia, R.H.. Hromockyj, A.E., Monack, D., Ramakrishnan, L., and Falkow, S. 1996. Applications for green fluorescent protein (GFP) in the study of host-pathogen interactions. Gene. 173: 47-52.